Phase III clinical trials for stem cell-based cartilage regeneration therapy have started

A group of researchers developed a synthetic tissue using synovium-derived mesenchymal stem cells (MSCs) for treating damaged cartilage, which had previously been incurable and had no effective therapies.

Share this post:


 

Related Posts